NBIX logo

Neurocrine Biosciences (NBIX) Current liabilities

annual current liabilities:

$507.70M-$147.10M(-22.46%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total current liabilities is $507.70 million, with the most recent change of -$147.10 million (-22.46%) on December 31, 2024.
  • During the last 3 years, NBIX annual current liabilities has risen by +$261.90 million (+106.55%).
  • NBIX annual current liabilities is now -22.46% below its all-time high of $654.80 million, reached on December 31, 2023.

Performance

NBIX Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly current liabilities:

$522.90M+$15.20M(+2.99%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total current liabilities is $522.90 million, with the most recent change of +$15.20 million (+2.99%) on March 31, 2025.
  • Over the past year, NBIX quarterly current liabilities has dropped by -$190.00 million (-26.65%).
  • NBIX quarterly current liabilities is now -26.65% below its all-time high of $712.90 million, reached on March 31, 2024.

Performance

NBIX quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NBIX Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-22.5%-26.6%
3 y3 years+106.5%+106.3%
5 y5 years-10.2%+272.7%

NBIX Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-22.5%+106.5%-26.6%+106.3%
5 y5-year-22.5%+172.2%-26.6%+272.7%
alltimeall time-22.5%>+9999.0%-26.6%>+9999.0%

NBIX Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$522.90M(+3.0%)
Dec 2024
$507.70M(-22.5%)
$507.70M(+18.2%)
Sep 2024
-
$429.70M(+7.8%)
Jun 2024
-
$398.50M(-44.1%)
Mar 2024
-
$712.90M(+8.9%)
Dec 2023
$654.80M(+21.8%)
$654.80M(-5.3%)
Sep 2023
-
$691.60M(+18.7%)
Jun 2023
-
$582.50M(+55.7%)
Mar 2023
-
$374.10M(-30.4%)
Dec 2022
$537.70M(+118.8%)
$537.70M(+10.8%)
Sep 2022
-
$485.10M(+69.8%)
Jun 2022
-
$285.70M(+12.7%)
Mar 2022
-
$253.50M(+3.1%)
Dec 2021
$245.80M(+31.8%)
$245.80M(+8.8%)
Sep 2021
-
$225.90M(+6.1%)
Jun 2021
-
$212.90M(+12.1%)
Mar 2021
-
$190.00M(+1.9%)
Dec 2020
$186.50M(-67.0%)
$186.50M(-69.5%)
Sep 2020
-
$611.00M(+6.6%)
Jun 2020
-
$573.00M(+308.4%)
Mar 2020
-
$140.30M(-75.2%)
Dec 2019
$565.30M(+540.7%)
$565.30M(+388.8%)
Sep 2019
-
$115.65M(+15.0%)
Jun 2019
-
$100.59M(+39.7%)
Mar 2019
-
$72.00M(-18.4%)
Dec 2018
$88.23M(+62.1%)
$88.23M(-80.7%)
Sep 2018
-
$456.40M(+639.0%)
Jun 2018
-
$61.76M(+32.9%)
Mar 2018
-
$46.47M(-14.6%)
Dec 2017
$54.43M(+79.0%)
$54.43M(+42.7%)
Sep 2017
-
$38.14M(+37.6%)
Jun 2017
-
$27.72M(+17.6%)
Mar 2017
-
$23.56M(-22.5%)
Dec 2016
$30.41M(+18.3%)
$30.41M(+14.1%)
Sep 2016
-
$26.67M(-0.9%)
Jun 2016
-
$26.90M(+15.6%)
Mar 2016
-
$23.28M(-9.5%)
Dec 2015
$25.71M(+64.2%)
$25.71M(+29.7%)
Sep 2015
-
$19.82M(+12.9%)
Jun 2015
-
$17.55M(+15.6%)
Mar 2015
-
$15.19M(-3.0%)
Dec 2014
$15.66M(+33.9%)
$15.66M(+11.5%)
Sep 2014
-
$14.04M(+16.5%)
Jun 2014
-
$12.05M(+13.6%)
Mar 2014
-
$10.61M(-9.3%)
Dec 2013
$11.70M(-25.2%)
$11.70M(-12.2%)
Sep 2013
-
$13.32M(-8.6%)
Jun 2013
-
$14.57M(+5.0%)
Mar 2013
-
$13.88M(-11.3%)
Dec 2012
$15.65M(-66.8%)
$15.65M(-32.3%)
Sep 2012
-
$23.11M(-20.7%)
Jun 2012
-
$29.15M(-20.4%)
Mar 2012
-
$36.63M(-22.2%)
Dec 2011
$47.11M(-10.7%)
$47.11M(-2.8%)
Sep 2011
-
$48.44M(-3.1%)
Jun 2011
-
$49.99M(+2.0%)
Mar 2011
-
$49.03M(-7.1%)
Dec 2010
$52.78M
$52.78M(-0.8%)
DateAnnualQuarterly
Sep 2010
-
$53.18M(+2.0%)
Jun 2010
-
$52.12M(+179.8%)
Mar 2010
-
$18.63M(-6.7%)
Dec 2009
$19.96M(-23.5%)
$19.96M(-17.0%)
Sep 2009
-
$24.04M(-27.2%)
Jun 2009
-
$33.02M(+1.5%)
Mar 2009
-
$32.54M(+24.7%)
Dec 2008
$26.09M(-12.7%)
$26.09M(+37.5%)
Sep 2008
-
$18.98M(-2.7%)
Jun 2008
-
$19.49M(+8.5%)
Mar 2008
-
$17.97M(-39.9%)
Dec 2007
$29.91M(+48.7%)
$29.91M(+49.4%)
Sep 2007
-
$20.02M(+5.7%)
Jun 2007
-
$18.94M(+6.3%)
Mar 2007
-
$17.82M(-11.4%)
Dec 2006
$20.12M(-40.3%)
$20.12M(-5.4%)
Sep 2006
-
$21.27M(-11.1%)
Jun 2006
-
$23.93M(-26.9%)
Mar 2006
-
$32.76M(-2.8%)
Dec 2005
$33.69M(-43.5%)
$33.69M(-3.8%)
Sep 2005
-
$35.04M(-13.0%)
Jun 2005
-
$40.29M(-14.6%)
Mar 2005
-
$47.18M(-20.8%)
Dec 2004
$59.59M(-45.8%)
$59.59M(-17.4%)
Sep 2004
-
$72.11M(+6.8%)
Jun 2004
-
$67.50M(-30.8%)
Mar 2004
-
$97.54M(-11.3%)
Dec 2003
$110.01M(+238.7%)
$110.01M(-4.6%)
Sep 2003
-
$115.27M(+13.4%)
Jun 2003
-
$101.61M(+4.7%)
Mar 2003
-
$97.08M(+198.9%)
Dec 2002
$32.48M(+31.2%)
$32.48M(+9.7%)
Sep 2002
-
$29.61M(+25.3%)
Jun 2002
-
$23.63M(-0.1%)
Mar 2002
-
$23.66M(-4.5%)
Dec 2001
$24.76M(+65.5%)
$24.76M(+10.5%)
Sep 2001
-
$22.41M(+74.4%)
Jun 2001
-
$12.85M(+6.2%)
Mar 2001
-
$12.09M(-19.2%)
Dec 2000
$14.96M(+73.9%)
$14.96M(+44.2%)
Sep 2000
-
$10.38M(+46.7%)
Jun 2000
-
$7.07M(-28.8%)
Mar 2000
-
$9.93M(+15.5%)
Dec 1999
$8.60M(+53.6%)
$8.60M(+72.0%)
Sep 1999
-
$5.00M(+35.1%)
Jun 1999
-
$3.70M(0.0%)
Mar 1999
-
$3.70M(-33.9%)
Dec 1998
$5.60M(-20.0%)
$5.60M(+9.8%)
Sep 1998
-
$5.10M(+50.0%)
Jun 1998
-
$3.40M(-29.2%)
Mar 1998
-
$4.80M(-31.4%)
Dec 1997
$7.00M(+70.7%)
$7.00M(+32.1%)
Sep 1997
-
$5.30M(-3.6%)
Jun 1997
-
$5.50M(+22.2%)
Mar 1997
-
$4.50M(+9.8%)
Dec 1996
$4.10M
$4.10M(+51.9%)
Sep 1996
-
$2.70M(-20.6%)
Jun 1996
-
$3.40M(+54.5%)
Mar 1996
-
$2.20M

FAQ

  • What is Neurocrine Biosciences annual total current liabilities?
  • What is the all time high annual current liabilities for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual current liabilities year-on-year change?
  • What is Neurocrine Biosciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly current liabilities year-on-year change?

What is Neurocrine Biosciences annual total current liabilities?

The current annual current liabilities of NBIX is $507.70M

What is the all time high annual current liabilities for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total current liabilities is $654.80M

What is Neurocrine Biosciences annual current liabilities year-on-year change?

Over the past year, NBIX annual total current liabilities has changed by -$147.10M (-22.46%)

What is Neurocrine Biosciences quarterly total current liabilities?

The current quarterly current liabilities of NBIX is $522.90M

What is the all time high quarterly current liabilities for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total current liabilities is $712.90M

What is Neurocrine Biosciences quarterly current liabilities year-on-year change?

Over the past year, NBIX quarterly total current liabilities has changed by -$190.00M (-26.65%)
On this page